1428 10 (Farxiga 10 mg)
Generic Name: dapagliflozin
This pill with imprint "1428 10" is Yellow, Four-sided and has been identified as Farxiga 10 mg. It is manufactured by Bristol-Myers Squibb Company.
Farxiga is used in the treatment of diabetes, type 2 and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Farxiga 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- dapagliflozin
- Imprint:
- 1428 10
- Strength:
- 10 mg
- Color:
- Yellow
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- SGLT-2 inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb Company
More about Farxiga (dapagliflozin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 53 Reviews – Add your own review/rating
- Drug class: SGLT-2 inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
